Skip to main content

Find Clinical Trials

Home
Conditions
Virus Diseases

Clinical trial condition

Virus Diseases

Explore clinical trials studying Virus Diseases. Study availability and eligibility vary by location and protocol.

94 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Virus Diseases trial results

Completed

Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011)

NCT01553279

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Infections, +2 more
Locations: Not specified

View Trial Details

Completed

Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010)

NCT01839188

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Infections, +2 more
Locations: Not specified

View Trial Details

Completed

Active Surveillance for Adverse Events Following Immunization With the Butantan Trivalent Influenza Vaccine (2018)

NCT03392207

Conditions: Infections, Influenza, Human, Orthomyxoviridae Infections, +6 more
Locations: Crie - Unifesp São Paulo, Brazil

Avenida Vital Brasil 1500 São Paulo, Brazil

View Trial Details

Completed

Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005)

NCT01337167

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +34 more
Locations: Not specified

View Trial Details

Completed

A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006)

NCT01340937

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +34 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Children

NCT02548078

Conditions: Infections, Virus Diseases
Locations: GSK Investigational Site Bamako, Mali

GSK Investigational Site Dakar, Senegal

View Trial Details

Completed

A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Adults

NCT02485301

Conditions: Infections, Virus Diseases
Locations: GSK Investigational Site Bamenda, Cameroon

GSK Investigational Site Yaoundé, Cameroon

GSK Investigational Site Bamako, Mali

GSK Investigational Site Abuja, Nigeria

View Trial Details

Completed

Intravenous Vitamin C in the Treatment of Viral Infection, Especially in the Treatment of Shingles

NCT00921934

Conditions: DNA Virus Infections, Herpes Simplex, Herpes Zoster, +8 more
Locations: Praxis Dr. Schencking, Rheinstr. 77a Ransbach-Baumbach, Rhineland-Palatinate, Germany

View Trial Details

Completed

Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster Vaccination

NCT01839175

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Infections, +2 more
Locations: Sanofi Pasteur MSD Investigational Site 003 Espoo, Finland

Sanofi Pasteur MSD Investigational Site 001 Helsinki, Finland

Sanofi Pasteur MSD Investigational Site 002 Helsinki, Finland

Sanofi Pasteur MSD Investigational Site 011 Jarvenpaa, Finland

View Trial Details

Completed

Study of the Immunogenicity and Safety of a Challenge Dose of HBVAXPRO in Healthy Children Vaccinated 10 Years Ago With 3 Doses of HEXAVAC or INFANRIX HEXA

NCT02012998

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: Sanofi Pasteur MSD Investigational Site 004 Bologna, Italy

Sanofi Pasteur MSD Investigational Site 009 Cagliari, Italy

Sanofi Pasteur MSD Investigational Site 005 Capannori, Italy

Sanofi Pasteur MSD Investigational Site 003 Chiavari, Italy

View Trial Details